Fact checked by Nick Blackmer Zunveyl (benzgalantamine)—a better-tolerated version of the Alzheimer’s drug Razadyne ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Approvals for drugs from Biogen Inc. and Sarepta Therapeutics Inc. show flaws in the process US drug regulators use to speed ...

"The view out there in the analyst community is that the future of Biogen depends on the next deal that we do and that's not ...

By 2060, 1 million adults per year will develop dementia, according to a study published in Nature Medicine. Also in the news, chronic cannabis use may lead to chronic illness; Eli Lilly hopes to ...

In a new study published in The BMJ, we and our colleagues Vishal Patel and Michael Liu, also at Harvard, set out to study rates of Alzheimer’s deaths among taxi drivers and ambulance drivers, who ...

Greg Lipschitz, Executive Chairman of Firefly, said, “This breakthrough underscores our commitment to pushing the boundaries of innovation in brain health, ultimately with the aim of making a ...

Johnson & Johnson's $14.6bn acquisition of Intra-Cellular Therapies adds Caplyta and a robust pipeline targeting major ...

If you read all ten of these non-fiction titles in the next couple of months, you’d be 67% of the way to the average number ...

Damond Reynard Lockett, 51, was convicted on charges of possession with intent to distribute heroin and fentanyl and ...

The updated guidance, which was largely driven by lower-than-anticipated sales of GLP-1 blockbusters Mounjaro and Zepbound, ...